COMT Val158Met genotype influences neurodegeneration within dopamineinnervated brain structures

E. D. Gennatas, J. A. Cholfin, J. Zhou, R. K. Crawford, D. A. Sasaki, A. Karydas, A. L. Boxer, S. J. Bonasera, K. P. Rankin, M. L. Gorno-Tempini, H. J. Rosen, J. H. Kramer, M. Weiner, B. L. Miller, W. W. Seeley

Research output: Contribution to journalArticlepeer-review

26 Scopus citations


Objective: We sought to determine whether the Val158Met polymorphism in the catechol-Omethyltransferase (COMT) gene influences neurodegeneration within dopamine-innervated brain regions. Methods: A total of 252 subjects, including healthy controls and patients with Alzheimer disease, behavioral variant frontotemporal dementia, and semantic dementia, underwent COMT genotyping and structural MRI. Results: Whole-brain voxel-wise regression analyses revealed that COMT Val158Met Val allele dosage, known to produce a dose-dependent decrease in synaptic dopamine (DA) availability, correlated with decreased gray matter in the region of the ventral tegmental area (VTA), ventromedial prefrontal cortex, bilateral dorsal midinsula, left dorsolateral prefrontal cortex, and right ventral striatum. Unexpectedly, patients carrying a Met allele showed greater VTA volumes than age-matched controls. Gray matter intensities within COMT-related brain regions correlated with cognitive and behavioral deficits. Conclusions: The results are consistent with the hypothesis that increased synaptic DA catabolism promotes neurodegeneration within DA-innervated brain regions.

Original languageEnglish (US)
Pages (from-to)1663-1669
Number of pages7
Issue number21
StatePublished - May 22 2012

ASJC Scopus subject areas

  • Clinical Neurology


Dive into the research topics of 'COMT Val158Met genotype influences neurodegeneration within dopamineinnervated brain structures'. Together they form a unique fingerprint.

Cite this